Dr. Amol Navathe is an Assistant Professor of Health Policy and Medicine and a Senior Fellow at the Leonard Davis Institute for Health Economics at the University of Pennsylvania. Dr. Navathe is a practicing physician, health economist, and engineer. He has extensive expertise in policy analysis and design, physician and hospital economic behavior, and application of informatics and predictive analytics to health care data. His work on advanced health data analytics and technology to improve healthcare delivery has been implemented at numerous large health systems. He has applied his skills to payment and delivery transformation, federal policy for health care evidence development and data infrastructure, and the study of physician and hospital economic behavior. Dr. Navathe completed his medical training at the University of Pennsylvania School of Medicine and his post-graduate medical training at the Brigham and Women’s Hospital at Harvard Medical School. He obtained his PhD in Health Care Management and Economics from The Wharton School at the University of Pennsylvania.
- Amy P. Abernethy, US FDA
- Graeme Archer, GSK R&D
- Jesse Berlin, Johnson & Johnson
- Lawrence Carin, Duke
- Noémie Elhadad, Columbia
- Igor Jurisica, Krembil Research Institute and University of Toronto
- Faisal Khan, AstraZeneca
- Kannan Natarajan, Pfizer
- Amol Navathe, University of Pennsylvania
- Adler Perotte, Columbia
- Patrick Ryan, Janssen Research and Development
- Mary Ann Slack, US Food and Drug Administration (FDA)
- Simon Tavaré, Columbia
- Mihaela van der Schaar, Cambridge
- Li Wang, AbbVie
Countdown to AIPM
AIPM has begun!
Welcome Address — David Madigan, Ph.D., Columbia University
A Perspective on the Promise and Pitfalls of Artificial Intelligence in Clinical Drug Development — Kannan Natarajan, Pfizer Inc.
Machine Learning: Changing the future of healthcare – from next generation clinical trials to individualized treatment effects — Mihaela van der Schaar, University of Cambridge
Discussant — Patrick Ryan, Janssen Research and Development
ML and AI in Clinical Development and Statistical Innovation — Wang Li, AbbVie.
Opportunities for AI in Healthcare — Lawrence Carin, Duke University
- Demissie Alemayehu, Pfizer Inc.
- David Madigan, Columbia University